TearScience has developed innovative technologies like LipiView II, LipiScan with Dynamic Meibomian Imaging (DMI), and the Korb Meibomian Gland Evaluator to assess and treat MGD. Their flagship product, LipiFlow, uses Vectored Thermal Pulse (VTP) technology to provide targeted treatment for MGD. Clinical studies have shown the safety and effectiveness of LipiFlow. TearScience's integrated system helps eye care professionals address the root cause of evaporative dry eye, which affects a large portion of the global dry eye population.